Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Hold from Sell at Craig-Hallum with analyst Bradley Berning saying the stock has now factored in decelerating revenues from increased competition and the push to drive margins that has come at the expense of seller transaction growth. 2. CACI (CACI) added to Conviction Buy at Goldman Sachs with analyst Gavin Parsons saying he expects the company's accelerating organic revenue growth to drive higher estimates and generate a re-rating in the multiple on the stock. 3. Zimmer Biomet (ZBH) upgraded to Buy from Hold at Canaccord with analyst Kyle Rose saying he believes the company is approaching the apex of its turnaround and is now on the cusp of a multi-year cycle of accelerating top-line growth that should translate to incremental leverage opportunities in 2020 and beyond. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Consensus $20.31. Raises FY24 revenue view to $7.5B-$7.6B from $7.3B-$7.5B, consensus $7.4B.

Reports Q3 revenue $1.94B, consensus $1.86B. "CACI's outstanding performance reflects the continued successful execution of our strategy. We're winning and delivering in the marketplace with differentiated capabilities, exceptional business development, and program execution," said John Mengucci, CEO. "Our third quarter results were strong across the board, including double-digit organic growth, margin expansion, $3.5 billion of awards, and record backlog. Our performance enables us to again raise fiscal year 2024 revenue and earnings guidance. We remain confident in our ability to drive long-term growth, increase free cash flow, and generate value for our customers and our shareholders."